Landles C, Osborne G, Phillips J, Canibano-Pico M, Nita I, Ali N
Brain Commun. 2024; 6(6):fcae410.
PMID: 39713241
PMC: 11660907.
DOI: 10.1093/braincomms/fcae410.
Winston G, Nilchian P, Greenfield J, Jones D
J Neurosurg Case Lessons. 2024; 8(23).
PMID: 39622045
PMC: 11616147.
DOI: 10.3171/CASE24512.
Pengo M, Squitieri F
Genes (Basel). 2024; 15(6).
PMID: 38927742
PMC: 11203031.
DOI: 10.3390/genes15060807.
Oosterloo M, Touze A, Byrne L, Achenbach J, Aksoy H, Coleman A
J Huntingtons Dis. 2024; 13(2):149-161.
PMID: 38669553
PMC: 11307030.
DOI: 10.3233/JHD-231523.
Bondulich M, Phillips J, Canibano-Pico M, Nita I, Byrne L, Wild E
Brain Commun. 2024; 6(1):fcae030.
PMID: 38370446
PMC: 10873584.
DOI: 10.1093/braincomms/fcae030.
PolyQ-Expansion Causes Mitochondria Fragmentation Independent of Huntingtin and Is Distinct from Traumatic Brain Injury (TBI)/Mechanical Stress-Mediated Fragmentation Which Results from Cell Death.
Swinter K, Salah D, Rathnayake R, Gunawardena S
Cells. 2023; 12(19).
PMID: 37830620
PMC: 10572422.
DOI: 10.3390/cells12192406.
Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 Patients.
Vishnevetsky A, Cornejo-Olivas M, Sarapura-Castro E, Inca-Martinez M, Rabinowitz D, Milla-Neyra K
Mov Disord Clin Pract. 2023; 10(2):238-247.
PMID: 36825038
PMC: 9941913.
DOI: 10.1002/mdc3.13625.
Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches.
Smith E, Sathasivam K, Landles C, Osborne G, Mason M, Gomez-Paredes C
Brain Commun. 2023; 5(1):fcad010.
PMID: 36756307
PMC: 9901570.
DOI: 10.1093/braincomms/fcad010.
CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington's Disease Monkeys.
Cho I, Clever F, Hong G, Chan A
Biomedicines. 2022; 10(8).
PMID: 36009409
PMC: 9405741.
DOI: 10.3390/biomedicines10081863.
Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.
Hasnain N, Arif T, Shafaut R, Zakaria F, Fatima S, Haque I
Wien Med Wochenschr. 2022; 174(5-6):87-94.
PMID: 35723821
DOI: 10.1007/s10354-022-00941-2.
Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington's disease.
Zhou Y, Peskett T, Landles C, Warner J, Sathasivam K, Smith E
Acta Neuropathol Commun. 2021; 9(1):70.
PMID: 33853668
PMC: 8048291.
DOI: 10.1186/s40478-021-01172-z.
Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington's disease symptoms.
Vega O, Cepeda C
Rev Neurosci. 2021; 32(8):871-886.
PMID: 33818039
PMC: 10017201.
DOI: 10.1515/revneuro-2021-0013.
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease.
Bondulich M, Fan Y, Song Y, Giorgini F, Bates G
Sci Rep. 2021; 11(1):5484.
PMID: 33750843
PMC: 7943810.
DOI: 10.1038/s41598-021-84858-7.
Development of novel bioassays to detect soluble and aggregated Huntingtin proteins on three technology platforms.
Landles C, Milton R, Jean A, McLarnon S, McAteer S, Taxy B
Brain Commun. 2021; 3(1):fcaa231.
PMID: 33604571
PMC: 7878250.
DOI: 10.1093/braincomms/fcaa231.
The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington's Disease: A Historical Perspective.
Monckton D
J Huntingtons Dis. 2021; 10(1):7-33.
PMID: 33579863
PMC: 7990401.
DOI: 10.3233/JHD-200429.
Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease.
Zhao X, Kumari D, Miller C, Kim G, Hayward B, Vitalo A
J Huntingtons Dis. 2021; 10(1):149-163.
PMID: 33579860
PMC: 7990428.
DOI: 10.3233/JHD-200423.
New developments in Huntington's disease and other triplet repeat diseases: DNA repair turns to the dark side.
Lahue R
Neuronal Signal. 2020; 4(4):NS20200010.
PMID: 33224521
PMC: 7672267.
DOI: 10.1042/NS20200010.
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease Model.
Landles C, Milton R, Ali N, Flomen R, Flower M, Schindler F
Brain Commun. 2020; 2(2):fcaa066.
PMID: 32954323
PMC: 7425396.
DOI: 10.1093/braincomms/fcaa066.
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.
Tabrizi S, Flower M, Ross C, Wild E
Nat Rev Neurol. 2020; 16(10):529-546.
PMID: 32796930
DOI: 10.1038/s41582-020-0389-4.
Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease.
Zielonka D, Stawinska-Witoszynska B
Front Neurol. 2020; 11:571.
PMID: 32733356
PMC: 7358529.
DOI: 10.3389/fneur.2020.00571.